Dr. Khong On The Benefit Of Neoadjuvant Endocrine Therapy In Er+ Breast Cancers

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Dr. Khong on Endocrine Combinations in ER+/HER2- Breast Cancer

ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer

Dr. Judy Boughey on Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Evaluating the Role of Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Neoadjuvant Endocrine Therapy in Breast Cancer

Dr. Mamounas on the Role of Extended Adjuvant Endocrine Therapy in ER+ Breast Cancer

Dr. Melisko on the Role of Neoadjuvant Chemotherapy in ER+ Cancer

Neoadjuvant hormonal treatment for luminal breast cancer: rationale, evidence and outcome

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

NEOS: prognosis of ER+ breast cancer pts who received neoadjuvant ET with/without adjuvant chemo

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

Dr. Callahan on Endocrine Therapy in Patients With ER-Positive Breast Cancer

Dr. Mamounas on Adjuvant Endocrine Therapy for Breast Cancer

Neoadjuvant Therapy for HR+ Breast Cancer